Maria Carell CEO & President of Revision Skincare & Goodier Cosmetics was named an Entrepreneur Of The Year 2022 Central Plains Award winner. 07.01.22
Ernst & Young announced that Maria Carell CEO & President of Revision Skincare & Goodier Cosmetics was named an Entrepreneur Of The Year 2022 Central Plains Award winner. Entrepreneur Of The Year is one of the preeminent competitive business awards for entrepreneurs and leaders of high-growth companies who think big to succeed. An independent panel of judges selected Carell based on her entrepreneurial spirit, purpose, growth and impact, among other core contributions and attributes. Ms. Carell commented, "I'm honored to have been selected as an Award Winner of EY's Central Plain Entrepreneur of the Year 2022. Since joining Revision Skincare & Goodier Cosmetics, I have been fortunate to work with an exceptional team to develop the company into one of the leaders of our industry. I'm proud of everything we have achieved and know this wouldn't be possible without my team." For more than two decades, Revision Skincare has provided dermatologists, plastic surgeons and medical spas with clinically proven, high-performing skincare products. Using only premium quality ingredients, the Revision Skincare collection was formulated to provide targeted solutions for enhancing skin's appearance and reducing signs of aging without ever compromising the long term health of the skin. Based in Irving, Texas, Revision Skincare is sold in more than 16 countries. As a Central Plains award winner, Carell will now be considered by the National independent panel of judges for the Entrepreneur Of The Year 2022 National Awards. National finalists and winners, as well as the Entrepreneur Of The Year National Overall Award winner, will be announced in November at the annual Strategic Growth Forum. The Entrepreneur Of The Year National Overall Award winner will then move on to compete for the EY World Entrepreneur Of The Year™ Award in June 2023. Related Content

Revision Skincare Exec Wins Ernst & Young Entrepreneur of the Year

News provided by
Share this article
Share this article
DALLAS, June 29, 2022 /PRNewswire/ -- Ernst & Young LLP (EY US) today announced that Maria Carell CEO & President of Revision Skincare® & Goodier Cosmetics was named an Entrepreneur Of The Year® 2022 Central Plains Award winner. Entrepreneur Of The Year is one of the preeminent competitive business awards for entrepreneurs and leaders of high-growth companies who think big to succeed. An independent panel of judges selected Carell based on her entrepreneurial spirit, purpose, growth and impact, among other core contributions and attributes. Ms. Carell commented, "I'm honored to have been selected as an Award Winner of EY's Central Plain Entrepreneur of the Year 2022. Since joining Revision Skincare & Goodier Cosmetics, I have been fortunate to work with an exceptional team to develop the company into one of the leaders of our industry. I'm proud of everything we have achieved and know this wouldn't be possible without my team." For more than two decades, Revision Skincare has provided dermatologists, plastic surgeons and medical spas with clinically proven, high-performing skincare products. Using only premium quality ingredients, the Revision Skincare collection was formulated to provide targeted solutions for enhancing skin's appearance and reducing signs of aging without ever compromising the long term health of the skin. Based in Irving, Texas, Revision Skincare is sold in more than 16 countries. As a Central Plains award winner, Carell will now be considered by the National independent panel of judges for the Entrepreneur Of The Year 2022 National Awards. National finalists and winners, as well as the Entrepreneur Of The Year National Overall Award winner, will be announced in November at the annual Strategic Growth Forum®. The Entrepreneur Of The Year National Overall Award winner will then move on to compete for the EY World Entrepreneur Of The Year™ Award in June 2023. The Entrepreneur Of The Year program has honored the inspirational leadership of entrepreneurs such as:
Baxter and Amber Venz Box of rewardStyle
Michael Browning, Jr. of Unleashed Brands
Dennis Cail of Zirtue
Sponsors
Founded and produced by Ernst & Young LLP, the Entrepreneur Of The Year Awards are presented by PNC Bank and SAP. In Central Plains, sponsors also include Colliers International, Donnelley Financial Solutions LLC, Haynes and Boone LLP, Roach Howard Smith & Barton (RHSB), Vari, D CEO Magazine and Marquee Events. About Entrepreneur Of The Year® 
Entrepreneur Of The Year is the world's most prestigious business awards program for unstoppable entrepreneurs. These visionary leaders deliver innovation, growth and prosperity that transform our world. The program engages entrepreneurs with insights and experiences that foster growth. It connects them with their peers to strengthen entrepreneurship around the world. Entrepreneur Of The Year is the first and only truly global awards program of its kind. It celebrates entrepreneurs through regional and national awards programs in more than 145 cities in over 60 countries. National overall winners go on to compete for the EY World Entrepreneur Of The Year™ title. ey.com/us/eoy
About EY Private
As Advisors to the ambitious™, EY Private professionals possess the experience and passion to support private businesses and their owners in unlocking the full potential of their ambitions. EY Private teams offer distinct insights born from the long EY history of working with business owners and entrepreneurs. These teams support the full spectrum of private enterprises including private capital managers and investors and the portfolio businesses they fund, business owners, family businesses, family offices and entrepreneurs. Visit ey.com/us/private
About EY
EY exists to build a better working world, helping create long-term value for clients, people and society and build trust in the capital markets. Enabled by data and technology, diverse EY teams in over 150 countries provide trust through assurance and help clients grow, transform and operate. Working across assurance, consulting, law, strategy, tax and transactions, EY teams ask better questions to find new answers for the complex issues facing our world today. EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. Information about how EY collects and uses personal data and a description of the rights individuals have under data protection legislation are available via ey.com/privacy. EY member firms do not practice law where prohibited by local laws. For more information about our organization, please visit ey.com . Ernst & Young LLP is a client-serving member firm of Ernst & Young Global Limited operating in the US. About Revision Skincare®
Revision Skincare® is an industry leader in developing clinically-validated, high potency, transformative skincare products. Our unique formulation philosophy is an integrated approach that delivers maximum efficacy while maintaining long-term skin health. For more information, please visit revisionskincare.com @revisionskincare . Contact: Revision Skincare PR

09:00 EDT
EY Announces Maria Carell of Revision Skincare® & Goodier Cosmetics as an Entrepreneur Of The Year® 2022 Central Plain...

RoundTable Healthcare Partners Completes Sale  of Revision Skincare and Goodier Cosmetics to Gryphon Investors
RoundTable Healthcare Partners Completes Sale  of Revision Skincare and Goodier Cosmetics to Gryphon Investors
LAKE FOREST, IL, December 1, 2021 — RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has completed the previously-announced sale of Revision Skincare® and Goodier Cosmetics (collectively “Revision Goodier” or the “Company”) to Gryphon Investors (“Gryphon”). Terms of the transaction were not disclosed.Revision Skincare®, one of the first brands in the United States to be recommended and sold by skincare professionals, is known for its ground-breaking, effective and scientifically proven formulations, changing the way clinical skincare results are achieved. Revision offers products that enable patients and consumers to achieve beautiful skin without ever compromising the skin’s long-term health. The portfolio includes well-known franchises such as Nectifirm®, Intellishade®, D·E·J and Revox™. Goodier Cosmetics is a leading topical CDMO with a long history of creating quality products with significant commercial success. Goodier is known for developing innovative formulations that utilize the latest ingredients and technologies, and offering a full turnkey experience, from concept to final packaging. Goodier’s customers include high-growth emerging brands as well as established market-leading skincare brands. “On behalf of RoundTable and our investors, I would like to thank the outstanding management team and dedicated employees of Revision Goodier for helping to create such a valuable business,” said Pierre Frechette, Managing Partner of RoundTable and Chairman of Revision Goodier. “We believe that Gryphon will be an excellent partner for the Company and its employees and customers going forward.”
Maria Carell, Chief Executive Officer of Revision Goodier, added, “RoundTable has been a tremendous partner for Revision Goodier since their initial acquisition of the Company in 2016. They have supported strategic investments in the Company to meaningfully accelerate our organic revenue and earnings growth. We now look forward to entering our next phase of growth with Gryphon.”
Financo Raymond James acted as exclusive financial advisor to Revision Goodier, and Sidley Austin LLP acted as exclusive legal advisor to RoundTable in this transaction. ABOUT ROUNDTABLE HEALTHCARE PARTNERS
RoundTable Healthcare Partners, based in Lake Forest, IL, is an operating-oriented private equity firm focused exclusively on the healthcare industry. RoundTable partners with companies that can benefit from its extensive industry relationships and proven operating and transaction expertise. RoundTable has established a successful track record of working with owner/founders, family companies, management teams, entrepreneurs and corporate partners who share a vision and believe in the value creation potential of its partnership model. RoundTable has raised $3.45 billion in committed capital, including five equity funds totaling $2.85 billion and three subordinated debt funds totaling $600 million. More information about RoundTable Healthcare Partners can be found at www.roundtablehp.com.

RoundTable Healthcare Partners Completes Sale  of Revision Skincare and Goodier Cosmetics to Gryphon Investors

Gryphon Investors Acquires Revision Goodier
Gryphon Investors announces it has signed a definitive agreement to acquire Revision Skincare and Goodier Cosmetics . In partnership with Revision Goodier’s leadership team, including CEO Maria Carell, Gryphon will continue to invest in the company’s mission of developing and delivering clinically proven and highly efficacious skincare products to a global customer base and advance the company’s contract development and manufacturing capabilities. Financial terms of the transaction were not disclosed. The transaction is expected to close in the fourth quarter of 2021. For more than two decades, Revision Skincare has provided dermatologists, plastic surgeons and medical spas with clinically proven, high-performing skincare products. Using only premium quality ingredients, the Revision Skincare collection was formulated to provide targeted solutions for enhancing skin’s appearance and reducing signs of aging. Based in Irving, Texas, Revision Skincare is sold in more than 10 countries. Since 1922, Irving, TX-based Goodier Cosmetics has been a trusted developer and manufacturer in cosmetic and OTC topical skincare solutions. Differentiated by an industry renowned Innovation Center of Excellence, Goodier, along with its team of R&D chemists, engineers and regulatory experts, remains at the forefront of market trends, new technologies, ingredients and advancements in formulation science, a media release explains. “Revision has a unique position as a high-growth independent company in a compelling market. Skincare consumers are becoming more discerning about the products they use, and we are excited to invest in Revision’s mission to help bring carefully formulated and highly efficacious skincare products to a global customer base.”
— Gryphon Operating Partner Mike Ferry
“We are thrilled to partner with Maria and her outstanding team to support Revision’s movement to bring scientific credibility, quality, innovation, and elegance to the professional skincare market. We are equally excited about the opportunity to build on Goodier’s differentiated capabilities and deliver world-class service to some of the fastest growing brands across the prestige beauty and personal care space.”
— Eddie Douglas, Principal in Gryphon’s Consumer Group
“We are delighted to partner with the team at Gryphon as we enter our next phase of growth. Gryphon is an ideal partner given their knowledge of skincare, consumer health, and professionally-endorsed brands, and their investment will allow us to accelerate the incredible momentum we have built over the last few years.”
— Revision Goodier CEO Maria Carell
“Revision Goodier represents a bullseye opportunity for Gryphon and leverages our proactive focus of investing behind leading efficacious skincare brands. We are proud to be partnering with the Revision Goodier management team, leaders in the clinical, efficacious skincare category, and to be supporting the team through their next phase of growth.”
— Matt Farron, Partner and Head of Gryphon’s Consumer Group
Carell will continue to lead Revision Goodier’s management team. As part of the transaction, a number of Gryphon Executive Advisors will join Gryphon Operating Partner Mike Ferry, Gryphon Deal Partner Matt Farron, and Gryphon Principal Eddie Douglas on the Board of Directors. The transaction marks Gryphon’s third investment in skincare products and services and first investment in the physician dispensed skincare category, per the release. [Source(s): Gryphon Investors, PR Newswire]
Share:

Gryphon Investors Acquires Revision Goodier

Gryphon Investors Announces Acquisition Of Revision Goodier
Investment Will Support Leading Independent Skincare Brand's Mission to Bring Clinically Proven and High-Performing Products to a Global Customer Base and Enhance CDMO Growth
Author:
SAN FRANCISCO, Nov. 8, 2021 /PRNewswire/ -- Gryphon Investors ("Gryphon"), a leading middle-market private equity firm, today announced that it has signed a definitive agreement to acquire Revision Skincare and Goodier Cosmetics (collectively "Revision Goodier"). In partnership with Revision Goodier's leadership team, including CEO Maria Carell, Gryphon will continue to invest in the company's mission of developing and delivering clinically-proven and highly-efficacious skincare products to a global customer base and advance the company's contract development and manufacturing ("CDMO") capabilities. Financial terms of the transaction were not disclosed. The transaction is expected to close in the fourth quarter of 2021. For more than two decades, Revision Skincare® has provided dermatologists, plastic surgeons and medical spas with clinically proven, high-performing skincare products. Using only premium quality ingredients, the Revision Skincare collection was formulated to provide targeted solutions for enhancing skin's appearance and reducing signs of aging. Based in Irving, Texas, Revision Skincare is sold in more than 10 countries. Since 1922, Irving, TX-based Goodier Cosmetics has been a trusted developer and manufacturer in cosmetic and OTC topical skincare solutions. Differentiated by an industry renowned Innovation Center of Excellence, Goodier, along with its team of R&D chemists, engineers and regulatory experts, remains at the forefront of market trends, new technologies, ingredients and advancements in formulation science. Gryphon Operating Partner Mike Ferry said, "Revision has a unique position as a high-growth independent company in a compelling market. Skincare consumers are becoming more discerning about the products they use, and we are excited to invest in Revision's mission to help bring carefully formulated and highly efficacious skincare products to a global customer base." Eddie Douglas, Principal in Gryphon's Consumer Group, noted, "We are thrilled to partner with Maria and her outstanding team to support Revision's movement to bring scientific credibility, quality, innovation, and elegance to the professional skincare market. We are equally excited about the opportunity to build on Goodier's differentiated capabilities and deliver world-class service to some of the fastest growing brands across the prestige beauty and personal care space." Ms. Carell commented, "We are delighted to partner with the team at Gryphon as we enter our next phase of growth. Gryphon is an ideal partner given their knowledge of skincare, consumer health, and professionally-endorsed brands, and their investment will allow us to accelerate the incredible momentum we have built over the last few years." Matt Farron, Partner and Head of Gryphon's Consumer Group, added, "Revision Goodier represents a bullseye opportunity for Gryphon and leverages our proactive focus of investing behind leading efficacious skincare brands. We are proud to be partnering with the Revision Goodier management team, leaders in the clinical, efficacious skincare category, and to be supporting the team through their next phase of growth." Revision Goodier's management team will continue to be led by CEO Maria Carell. As part of the transaction, a number of Gryphon Executive Advisors will join Gryphon Operating Partner Mike Ferry, Gryphon Deal Partner Matt Farron, and Gryphon Principal Eddie Douglas on the Board of Directors. The transaction marks Gryphon's third investment in skincare products and services and first investment in the physician dispensed skincare category. William Blair & Company, LLC is serving as the exclusive financial advisors to Gryphon. Financo Raymond James is serving as financial advisors to Revision Goodier. Kirkland & Ellis LLP is acting as legal advisor to Gryphon, and Sidley Austin LLP is acting as legal advisor to Revision Goodier. Revision Skincare ® ("Revision"):One of the first brands to be sold through doctors' offices, Revision Skincare ® is known for its ground-breaking, effective and scientifically proven formulations, changing the way clinical skincare results are achieved. Revision offers products that are enabling patients and consumers to achieve beautiful skin without ever compromising the skin's long-term health. The portfolio includes well-known franchises such as Nectifirm ®, Intellishade ®, D ·E ·J and Revox™. Goodier Cosmetics ("Goodier"):Goodier is a leading skincare CDMO with a long history of creating quality products with significant commercial success. Goodier is known for developing innovative formulations that utilize the latest ingredients and technologies, and for bringing products from concept to a saleable finished good. Customers, including high-growth emerging brands and established market-leading brands, turn to Goodier for its flexible customer-centric service and full turn-key experience. Goodier stands out as one of the preferred CDMOs specializing in high-end topical solutions. About Gryphon InvestorsBased in San Francisco, Gryphon Investors ( www.gryphoninvestors.com ) is a leading private equity firm focused on profitably growing and competitively enhancing middle-market companies in partnership with experienced management. The firm has managed over $7.5 billion of equity investments and capital since 1997. Gryphon targets making equity investments of $50 million to $300 million in portfolio companies with enterprise values ranging from approximately $100 million to $600 million. Gryphon prioritizes investment opportunities where it can form strong partnerships with owners and executives to build leading companies, utilizing Gryphon's capital, specialized professional resources, and operational expertise. Contact:Lambert & Co. Caroline Luz203-656-2829 cluz@lambert.com or Jennifer Hurson845-507-0571 jhurson@lambert.com
View original content: https://www.prnewswire.com/news-releases/gryphon-investors-announces-acquisition-of-revision-goodier-301418309.html

Gryphon Investors Announces Acquisition Of Revision Goodier

Goodier Cosmetics

Stryker

Linkshare

Procter & Gamble

Merz Therapeutics

Acq - Fin - II

Revision Skincare is a marketer of physician direct dispensed products sold exclusively through dermatologists, plastic surgeons and other specialists.

Date	Round	Amount	Investors	Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.	Revenue	Sources
11/8/2021	Acq - Fin - II		Gryphon Investors		0 FY undefined	4
8/3/2016	Acq - Fin		Subscribe to see more		0 FY undefined	10

Date	11/8/2021	8/3/2016
Round	Acq - Fin - II	Acq - Fin
Amount
Investors	Gryphon Investors	Subscribe to see more
Valuation
Revenue	0 FY undefined	0 FY undefined
Sources	4	10

First funding	Last Funding	Investor	Rounds	Board Seats	Type	Location
11/8/2021	11/8/2021	Gryphon Investors	1 Acq - Fin - II		Private Equity	California
00/00/0000	00/00/0000	RoundTable Healthcare Partners	Subscribe to see more		Private Equity	Illinois

First funding	11/8/2021	00/00/0000
Last Funding	11/8/2021	00/00/0000
Investor	Gryphon Investors	RoundTable Healthcare Partners
Rounds	1 Acq - Fin - II	Subscribe to see more
Board Seats
Type	Private Equity	Private Equity
Location	California	Illinois

Wells Fargo Success Story

3M Success Story

Platform Overview

Revision Skincare

Investors Count

Revision Skincare Funding, Revision Skincare Valuation & Revision Skincare Revenue

Revision Skincare Investors

Discover the right solution for your team